They also demonstrated that overexpression of MAST1 or MAST2 fusions products had a proliferative effect both in vitro and in vivo, suggesting a possible role in carcinogenesis in a subset of breast carcinomas. This evidence concerns the gene MAST2 and breast carcinoma.